Fundraising Fox

Osmosis

Acquired

8 known investors

osmosis.org β†—

Osmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.

Also known as Osmosis from Elsevier Β· Osmosis.org

Investors Β· 8

Also in the syndicate Β· 2

Harvard Business School professorsJeff Bussganglead

Company profile

researched Aug 2026

Osmosis (osmosis.org) is a US-based digital health education company that produces short-form, illustrated video content and study tools for medical, nursing and allied health students, practicing clinicians, and patients. The platform applies evidence-based learning science to break complex medical concepts into what the company calls "microcontent" β€” modular learning units delivered online and via mobile, supplemented by a YouTube channel of educational videos.

The company was co-founded by Shiv Gaglani, who began the venture while a medical student at Johns Hopkins University and served as Co-Founder and CEO. Osmosis was acquired by the publisher Elsevier and became part of Elsevier's Global Medical Education portfolio, operating under the name "Osmosis from Elsevier." At the time of the acquisition announcement, the company reported reach in 195 countries, more than two million YouTube subscribers, over 150 institutional partnerships, and over a quarter of a billion content views. Around the acquisition period the organization described a global workforce of more than eighty-five educators, medical illustrators, video editors and related staff.

Note: several similarly named entities appear in public sources β€” a Cosmos-ecosystem DeFi protocol (osmosis.zone) and an AI reinforcement fine-tuning startup (osmosis.ai) β€” and are distinct from this company.

Founding story

Shiv Gaglani conceived Osmosis as a medical student at Johns Hopkins University, concluding that the century-old lecture-based approach to medical education could be made more personalized, dynamic and efficient. He took time off from the MD program to build the company, deferring medical school annually for about ten years while earning an MBA from Harvard in 2016. His first investors included his business school professors; Jeff Bussgang, who taught "Launching Technology Ventures" and is a managing director at Flybridge Capital, provided the company's first six-figure check.

Business model

Osmosis provides subscription-style access to a digital learning platform and video library for individual learners, and works with institutions β€” including medical schools and digital health companies β€” through partnerships. Following acquisition it operates as part of Elsevier's Global Medical Education portfolio.

Sources describe a learning platform serving subscribers and 150+ institutional partnerships, but do not disclose pricing or revenue figures.

Traction

At the acquisition announcement Osmosis reported reach in 195 countries, more than two million YouTube subscribers, over 150 institutional partnerships, and over 250 million content views. A podcast description around a year after the acquisition cited a global workforce of more than 85 educators, illustrators and video editors.

Latest developments

Osmosis operates as "Osmosis from Elsevier" within Elsevier's Global Medical Education portfolio. Elsevier stated it intends to apply Osmosis's microcontent approach to other segments of its healthcare portfolio, including nursing students and eventually patients. Co-founder and CEO Shiv Gaglani returned to Johns Hopkins to complete approximately a year and a half of remaining medical school while Elsevier accommodated a modified role.

β–ΈFull profile β€” market position, technology, go-to-market, geography, history, risks & controversies

Market position

Osmosis is positioned as a visual/short-form learning provider within digital health education. Elsevier framed the acquisition as complementing its existing digital medical education solutions and following its purchases of Shadow Health (virtual nursing simulations) and 3D4 Medical (Complete Anatomy 3D anatomy app).

Emphasis on highly visual, short-form microcontent grounded in learning science, combined with very large organic reach on YouTube and a broad international footprint.

Technology

The platform uses evidence-based learning science to create modular "microcontent" that converts complex medical concepts into short learning modules, delivered through web and mobile with content pushed to learners rather than relying on learners returning to the system. Earlier technology included a system that ingested users' uploaded lecture notes and generated related content recommendations.

Go-to-market

Distribution combines a large free-to-view YouTube channel that functions as a top-of-funnel audience channel, direct subscriptions, and institutional partnerships with medical schools and digital health companies. Post-acquisition, distribution is extended through Elsevier's global medical education channels.

Medical students, nursing and allied health students, residents, practicing clinicians, and β€” as an intended future segment under Elsevier β€” patients and their family members. Institutional customers include medical schools and digital health companies.

Geography

US-based with content reaching learners in 195 countries; parent company Elsevier is a global research publishing and information analytics firm.

History

Osmosis spent roughly its first two years building a technology platform that let users upload lecture notes and receive automatically generated content recommendations. Gaglani has said market demand proved to be concentrated in video content rather than that platform, prompting a pivot toward producing educational videos. The company subsequently scaled its video library and subscriber base, and was acquired by Elsevier, joining its Global Medical Education portfolio. After the acquisition, Elsevier accommodated Gaglani's return to Johns Hopkins to complete his clinical years of medical school.

Risks & controversies

No controversies are reported in the available sources. A notable research risk is name ambiguity: unrelated entities named Osmosis exist, including the osmosis.zone blockchain protocol and an osmosis.ai AI fine-tuning startup, which can contaminate automated data collection.

Compiled by commissioned research from 7 cited public sources β€” announcements, filings, and press listed under research sources below.

Key figures

latest reported
Countries reachedJan 2021195
Cumulative content viewsJan 2021250,000,000 views
Employees (global workforce of educators, illustrators, video editors and othersJan 202385 people
Institutional partnershipsJan 2021150 partnerships
YouTube subscribersJan 20212,000,000 subscribers

Company-reported or press-reported figures, each dated to when it was claimed β€” not independently audited.

Timeline Β· 2

launches, deals, and filings
Jan 2023
Co-founder and CEO Shiv Gaglani returns to medical school

Elsevier allowed Gaglani to structure his role so he could return to Johns Hopkins to complete roughly a year and a half of remaining clinical medical education.

source β†—

Jan 2021
Elsevier acquires Osmosis

Elsevier announced the acquisition of Osmosis, a US-based visual learning platform for health education. Osmosis joined Elsevier's Global Medical Education portfolio; terms were not disclosed. The deal followed Elsevier's acquisitions of Shadow Health and 3D4 Medical.

source β†—

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

β–ΈResearch sources Β· 7

primary sources listed

7 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Osmosis do?
Osmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
Who are Osmosis's investors?
Osmosis's investors include Felicis Ventures, Figure 8 Investments, Greycroft, Maryland TEDCO, Social Starts, TEDCO.